Vaginal Effects after Radiation Therapy in Anal Cancer Study

Not Applicable

Completed

• Conditions: Anal Cancer; Cancer - Bowel - Anal

• Registration Number: ACTRN12612001242819
• Lead Sponsor: Peter MacCallum Cancer Centre

Brief Summary

Data analysis is currently underway, results not yet available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-11-23
• Study Completion: 2021-12-21
• Last Update Posted: 21 August 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 32

Inclusion Criteria

Age 18 years or older.
Has provided written informed consent for participation in this trial.
Histological or cytologically confirmed anal cancer (all histological types).
Non-distant metastatic anal cancer.
ECOG performance status score of 2 or less.
Suitable for radical pelvic radiotherapy plus or minus concurrent chemotherapy.
Available for follow up.

Exclusion Criteria

Intended to received less than 45 Gy to pelvis i.e. not radical dose.
Participants who had or will require abdominoperineal resection due to changes in vaginal anatomy.
Significant psychiatric condition receiving active management which interferes with ability to comply with vaginal dilator use due to psychological reasons.

Study & Design

• Study Type: Interventional
• Study Design: Not specified